These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 16095010

  • 1. Treatment of intravenous immunoglobulin-resistant Kawasaki disease with methotrexate.
    Ahn SY, Kim DS.
    Scand J Rheumatol; 2005; 34(2):136-9. PubMed ID: 16095010
    [Abstract] [Full Text] [Related]

  • 2. Clinical Outcomes of Low-Dose Methotrexate Therapy as a Second-Line Drug for Intravenous Immunoglobulin-Resistant Kawasaki Disease.
    Jang H, Kim KY, Kim DS.
    Yonsei Med J; 2018 Jan; 59(1):113-118. PubMed ID: 29214785
    [Abstract] [Full Text] [Related]

  • 3. Low-dose methotrexate therapy for intravenous immunoglobulin-resistant Kawasaki disease.
    Lee TJ, Kim KH, Chun JK, Kim DS.
    Yonsei Med J; 2008 Oct 31; 49(5):714-8. PubMed ID: 18972590
    [Abstract] [Full Text] [Related]

  • 4. A case of intravenous immunoglobulin-resistant Kawasaki disease treated with methotrexate.
    Lee MS, An SY, Jang GC, Kim DS.
    Yonsei Med J; 2002 Aug 31; 43(4):527-32. PubMed ID: 12205742
    [Abstract] [Full Text] [Related]

  • 5. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
    Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM.
    Pediatrics; 2004 Dec 31; 114(6):e689-93. PubMed ID: 15545617
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
    Miyata K, Kaneko T, Morikawa Y, Sakakibara H, Matsushima T, Misawa M, Takahashi T, Nakazawa M, Tamame T, Tsuchihashi T, Yamashita Y, Obonai T, Chiga M, Hori N, Komiyama O, Yamagishi H, Miura M, Post RAISE group.
    Lancet Child Adolesc Health; 2018 Dec 31; 2(12):855-862. PubMed ID: 30337183
    [Abstract] [Full Text] [Related]

  • 7. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y.
    Arch Dis Child; 2008 Feb 31; 93(2):142-6. PubMed ID: 17962370
    [Abstract] [Full Text] [Related]

  • 8. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM, Silverman ED, McCrindle BW, Yeung RS.
    J Pediatr; 2002 Apr 31; 140(4):450-5. PubMed ID: 12006960
    [Abstract] [Full Text] [Related]

  • 9. Clinical outcomes of initial dexamethasone treatment combined with a single high dose of intravenous immunoglobulin for primary treatment of Kawasaki disease.
    Lim YJ, Jung JW.
    Yonsei Med J; 2014 Sep 31; 55(5):1260-6. PubMed ID: 25048483
    [Abstract] [Full Text] [Related]

  • 10. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH.
    PLoS One; 2015 Sep 31; 10(12):e0144603. PubMed ID: 26658843
    [Abstract] [Full Text] [Related]

  • 11. Kawasaki disease: a comprehensive review of treatment options.
    Patel RM, Shulman ST.
    J Clin Pharm Ther; 2015 Dec 31; 40(6):620-5. PubMed ID: 26547265
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and limitation of infliximab treatment for children with Kawasaki disease intractable to intravenous immunoglobulin therapy: report of an open-label case series.
    Mori M, Imagawa T, Hara R, Kikuchi M, Hara T, Nozawa T, Miyamae T, Yokota S.
    J Rheumatol; 2012 Apr 31; 39(4):864-7. PubMed ID: 22337241
    [Abstract] [Full Text] [Related]

  • 13. [Evaluation of unresponsiveness to standard high-dose gamma globulin therapy in Kawasaki disease].
    Tavli V, Yilmazer MM, Güven B, Meşe T, Oner T, Demirpençe S.
    Turk Kardiyol Dern Ars; 2010 Jan 31; 38(1):20-4. PubMed ID: 20215838
    [Abstract] [Full Text] [Related]

  • 14. [The role of immunosuppressive agents in Kawasaki disease: a discussion of two cases].
    Peyre M, Laroche C, Etchecopar C, Brosset P.
    Arch Pediatr; 2013 Jul 31; 20(7):748-53. PubMed ID: 23693156
    [Abstract] [Full Text] [Related]

  • 15. Recurrence of Fever After Initial Intravenous Immunoglobulin Treatment in Children With Kawasaki Disease.
    Yoshida M, Oana S, Masuda H, Ishiguro A, Kato H, Ito S, Kobayashi T, Abe J.
    Clin Pediatr (Phila); 2018 Feb 31; 57(2):189-192. PubMed ID: 28952328
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of intravenous immune globulin therapy combined with dexamethasone for the initial treatment of acute Kawasaki disease.
    Jibiki T, Terai M, Kurosaki T, Nakajima H, Suzuki K, Inomata H, Terashima I, Honda T, Yasukawa K, Hamada H, Kohno Y.
    Eur J Pediatr; 2004 Apr 31; 163(4-5):229-33. PubMed ID: 14963702
    [Abstract] [Full Text] [Related]

  • 17. Treatment of Kawasaki disease with a moderate dose (1 g/kg) of intravenous immunoglobulin.
    Khowsathit P, Hong-Hgam C, Khositseth A, Wanitkun S.
    J Med Assoc Thai; 2002 Nov 31; 85 Suppl 4():S1121-6. PubMed ID: 12549785
    [Abstract] [Full Text] [Related]

  • 18. Phase II Open Label Study of Anakinra in Intravenous Immunoglobulin-Resistant Kawasaki Disease.
    Koné-Paut I, Tellier S, Belot A, Brochard K, Guitton C, Marie I, Meinzer U, Cherqaoui B, Galeotti C, Boukhedouni N, Agostini H, Arditi M, Lambert V, Piedvache C.
    Arthritis Rheumatol; 2021 Jan 31; 73(1):151-161. PubMed ID: 32779863
    [Abstract] [Full Text] [Related]

  • 19. [Methylprednisolone pulse therapy in Kawasaki disease].
    Miura M, Matsuoka M, Kohno K, Ohki H, Yoshiba S.
    Nihon Rinsho; 2008 Feb 31; 66(2):338-42. PubMed ID: 18265457
    [Abstract] [Full Text] [Related]

  • 20. Epidemiologic study of Kawasaki disease and cases resistant to IVIG therapy in Thailand.
    Durongpisitkul K, Sangtawesin C, Khongphatthanayopthin A, Panamonta M, Sopontammarak S, Sittiwangkul R, Pongpanich B.
    Asian Pac J Allergy Immunol; 2006 Mar 31; 24(1):27-32. PubMed ID: 16913186
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.